MedTrace Logo

Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation

NCT03108430 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-04-11

No results posted yet for this study

Summary

Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.

Conditions

  • Inhalation Pneumonia
  • Risk Factor

Interventions

OTHER

Risk factors and incidence of IP after inhalation

Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-22
Primary Completion
2017-08-21
Completion
2017-08-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03108430 on ClinicalTrials.gov